FULC — Fulcrum Therapeutics Share News
0.000.00%
Last trade - 00:00- $280.77m
- -$38.07m
Brief: Alphabet Reports Stake In PayPay And CME Group, Dissolves In Dexcom
Fulcrum Therapeutics Q1 net loss widens on higher expenses
Brief: Fulcrum Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)
Fulcrum Therapeutics reports bigger Q4 net loss
Brief: Fulcrum Therapeutics Announces Positive Results From 20 Mg Dose Cohort Of Phase 1B Pioneer Trial Of Pociredir
Brief: Fulcrum Therapeutics Announces Pricing Of Upsized $175.0 Million Public Offering Of Common Stock And Pre-Funded Warrants
Fulcrum Therapeutics dips after unveiling $150 million share sale
U.S. STOCKS ON THE MOVE-Five Below, Boeing, Instacart
Buzz Us Stocks On The Move: Tesla, Warner Bros Discovery, Netflix
Fulcrum Therapeutics jumps after trial data of blood disorder drug
U.S. STOCKS ON THE MOVE-Micron, NextEra Energy, Ocular Therapeutix
Fulcrum Therapeutics rises after trial data of blood disorder drug
Brief: Fulcrum Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)
U.S. RESEARCH ROUNDUP- Alphabet, Boeing, KLA
Fulcrum Therapeutics' Q3 net loss narrows
Brief: Fulcrum Therapeutics Q3 Basic EPS USD -0.31
U.S. RESEARCH ROUNDUP- AGCO, Caterpillar, United Rentals
Brief: Fulcrum Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)
Fulcrum Therapeutics Inc reports results for the quarter ended June 30 - Earnings Summary